Hepatocellular carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Hepatocellular carcinoma (HCC) confirmed by pathological examination or two types of radiological imaging techniques. (2) Child-Pugh class A or B. (3) Presence of at least one measurable tumor lesion, defined according to the Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1). (4) At least one imaging examination performed within 3 months prior to the initiation of treatment.
Exclusion criteria
Exclusion criteria: (1) Presence of other primary tumors. (2) Non-adherence to lenvatinib combined with sintilimab treatment. (3) History of prior surgical treatment. (4) Non-hepatitis B virus (HBV)/hepatitis C virus (HCV) infection. (5) Unacceptable toxic reactions. (6) Incomplete follow-up data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Countries
China
Contacts
The Fifth Medical Center of the PLA General Hospital